pharmaphorum

SEPTEMBER 6, 2017

Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare. But how can healthcare systems make this transition – and how do pharmaceutical companies play a role in this, while also growing their market? A forthcoming webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet thi

Community Pharmacies 52

Community Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Med Ed 101

SEPTEMBER 27, 2017

If you haven’t come across a situation where you don’t know what to do, you probably haven’t been asked enough questions. Making recommendations is not easy sometimes. Getting questions when you don’t know the answer is part of life and growing as a professional. It is hard to admit you don’t know something, but I […].

40

40

Med Ed 101

SEPTEMBER 24, 2017

I work with a lot of geriatric patients in my practice on respiratory medications and I get pretty concerned when I start to see patients with COPD, asthma, or other respiratory diseases who have frequent exacerbations that are causing emergency department visits or hospitalizations. One of the most important things I review with patients is […].

Hospitals 40

Hospitals 40

Med Ed 101

SEPTEMBER 20, 2017

Patients often don’t understand drug interactions. In this scenario, I’ll discuss the statin and grapefruit juice interaction and really what we can do about it. For more clinical pearls on statins, be sure to check out this podcast! Upon assessment of a patient’s medications, your patient reports that she isn’t taking her statin medication.

40

40

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Med Ed 101

SEPTEMBER 17, 2017

Figuring out how and when to taper a PPI is a difficult question sometimes. Here’s a scenario and some of the items that I would look at. A 45 year old female has a past medical history of: GERD Hypertension Constipation Anemia Osteoarthritis With this minimal information available, I would definitely want the patient’s report […].

40

40

Med Ed 101

SEPTEMBER 13, 2017

Here’s a case scenario of possible medication induced QTc prolongation and some thoughts as to what I might do about it. The med list: Amitriptyline 150 mg once daily Geodon 80 mg BID Metformin 500 mg BID Ondansetron 8 mg TID prn Gabapentin 300 mg TID Ativan 1 mg daily Gipizide 5 mg daily Losartan […]. The post Case Review – Medication Induced QTc Prolongation appeared first on Med Ed 101.

40

40

Med Ed 101

SEPTEMBER 6, 2017

Drug induced lethargy is something that I see on a fairly regular basis. The challenging part is trying to identify which medication or medications are causing lethargy. A 61 year old female complains of constant lethargy and just feels like she could sleep all day and all night. She says that she probably lays in […]. The post Assessing Drug Induced Lethargy – Case Scenario appeared first on Med Ed 101.

40

40

Med Ed 101

SEPTEMBER 3, 2017

Antidepressant selection is a bit of an art. There are so many considerations that go into choosing which antidepressant should be utilized. Here’s a few things that I think about where making a recommendation. Pain. The TCA”s and SNRI’s do have some benefit in different pain syndromes like neuropathy and fibromyalgia. If a patient has […].

40

40

pharmaphorum

SEPTEMBER 19, 2017

Pharmaceutical marketers are increasingly native multichannel practitioners, but building an effective and efficient campaign is challenging. This is also because the digital landscape, and the number of options available is still rapidly evolving. What are the best ways to choose the right channels and the right content? And how can you plan to optimize operations further by cutting down on costs and approval times?

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52